Cytochrome P(450)-dependent toxic effects of primaquine on human erythrocytes.

Author: GanesanShobana, SahuRajnish, TekwaniBabu L, TripathiLalit M, WalkerLarry A

Paper Details 
Original Abstract of the Article :
Primaquine, an 8-aminoquinoline, is the drug of choice for radical cure of relapsing malaria. Use of primaquine is limited due to its hemotoxicity, particularly in populations with glucose-6-phosphate dehydrogenase deficiency [G6PD(-)]. Biotransformation appears to be central to the anti-infective a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.taap.2009.07.012

データ提供:米国国立医学図書館(NLM)

Primaquine: A Double-Edged Sword in Malaria Treatment

This research delves into the complex relationship between the antimalaria drug primaquine and its potential for hemotoxicity, a side effect that can damage red blood cells. The study investigates the role of cytochrome P(450) enzymes, a family of proteins responsible for metabolizing drugs in the body, in the detoxification and toxicity of primaquine. The researchers utilized an in vitro system to study the metabolism of primaquine by different cytochrome P(450) isoforms, revealing the specific isoforms involved in its hemotoxicity. This research provides important insights into the mechanisms underlying primaquine's toxicity and the potential for developing strategies to mitigate its harmful effects.

Metabolic Pathways and Hemotoxicity: A Delicate Balance

This research reveals the critical role of cytochrome P(450) enzymes in the metabolism and hemotoxicity of primaquine. The study identifies several specific cytochrome P(450) isoforms that are involved in the generation of toxic metabolites. This understanding paves the way for developing strategies to minimize the risk of hemotoxicity, potentially by targeting these specific isoforms or using alternative treatment regimens.

Primaquine: A Powerful Tool with Potential Risks

This research highlights the delicate balance between the therapeutic benefits and potential risks of primaquine. While this drug remains an effective treatment for malaria, its hemotoxicity poses a significant concern, particularly for individuals with glucose-6-phosphate dehydrogenase deficiency. It is crucial to consult with a healthcare professional to determine the appropriate use of primaquine and to ensure its safe and effective administration.

Dr.Camel's Conclusion

This research is a testament to the complex interplay between metabolism, genetics, and drug toxicity. The study's findings provide valuable insights into the mechanisms underlying primaquine's hemotoxicity, highlighting the importance of careful patient selection and personalized treatment strategies to optimize its therapeutic benefits while minimizing its potential risks.
Date :
  1. Date Completed 2009-11-04
  2. Date Revised 2022-03-16
Further Info :

Pubmed ID

19616568

DOI: Digital Object Identifier

10.1016/j.taap.2009.07.012

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.